Acetylsalicylic acid use in patients with acute myocardial infarction and peptic ulcer bleeding

Canadian Journal of Gastroenterology

Volumn 23, Issue 9, 2009, Pages 619-623

  Cheung, Justin ^a   Rajala, Jennifer ^a   Moroz, Daniel ^a   Zhu, Qiaohao ^b   Stamm, Michael ^a   Sandha, Gurpal Singh ^a  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b Integrated Centre for Care Advancement Through Research iCARE   (Canada)

Author keywords

Aspirin; Myocardial infarction; Nonvariceal bleeding; Peptic ulcer

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

AGED; ARTICLE; BLOOD TRANSFUSION; CHEMICALLY INDUCED DISORDER; DIGESTIVE TRACT ENDOSCOPY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HUMAN; MALE; MORTALITY; PEPTIC ULCER; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

AGED; ASPIRIN; BLOOD TRANSFUSION; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MYOCARDIAL INFARCTION; PEPTIC ULCER; PLATELET AGGREGATION INHIBITORS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 70350442905     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/509258     Document Type: Article

References (19)

1. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2007:50;e1-157.
2. Sanmuganathan PS, Ghahramani P, Jackson PR, et al. Aspirin for primary prevention of coronary disease: Safety and absolute benefit related to coronary risk derived from meta-analysis of randomized trials. Heart 2001;85:265-271 (Pubitemid 32973555)
3. Weisman SM, Graham DY. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med 2002;162:2197-2202.
4. Campbell CL, Smyth S, Montalescot G, Steinhubl SR. Aspirin dose for the prevention of cardiovascular disease. A systematic review. JAMA 2007;297:2018-2024 (Pubitemid 47236427)
5. Laine L. Gastrointestinal bleeding with low-dose aspirin - what's the risk? Aliment Pharmacol Ther 2006;24:897-908.
6. Barkun A, Bardou M, Marshall JK. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Int Med 2003;139:843-857 (Pubitemid 36383342)
7. Barkun A, Fallone CA, Chiba N, et al. Canadian clinical practice algorithm for the management of patients with nonvariceal upper gastrointestinal bleeding. Can J Gastroenterol 2004;18:605-609 (Pubitemid 39530065)
8. Palmer KR. Nonvariceal upper gastrointestinal haemorrhage guidelines. British Society of Gastroenterology Endoscopy Committee. Gut 2002;51:1-6.
9. Lau J, Sung J, Lee K, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding. N Engl J Med 2000;343:310-316 (Pubitemid 30616696)
10. Sung J, Chan F, Lau J, et al. The effect of endoscopic therapy in patients receiving omprezole for bleeding ulcers with nonbleeding visible vessels or adherent clots. Ann Intern Med 2003;139:237-243 (Pubitemid 38129084)
11. Lai KC, WH Hui, B Wong, et al. A retrospective and prospective study on the safety of discharging selected patients with duodenal ulcer bleeding on the same day as endoscopy. Gastrointest Endosc 1997;45:26-30.
12. Longstreth GF, Feitelberg SP, et al. Outpatient care of selected patients with acute non-variceal upper gastrointestinal hemorrhage. Lancet 1995;345;108-111
13. Ng FH, Wong BCY, SY Wong, et al. Clopidogrel plus omeprazole compared with aspirin plus omeprazole for aspirin-induced symptomatic peptic ulcers/erosions with low to moderate bleeding/ rebleeding risk - a single-blind randomized controlled study. Aliment Pharmacol Ther 2004;19:359-365
14. Sung JY, Lau J, Ching J, et al. Can aspirin be reintroduced with proton pump inhibitor infusion after endoscopic hemostasis? A double-blinded randomized control trial. Gastroenterology 2006;130(Suppl 2):A44. (Abst)
15. Chan FKL, Ching JYL, Hung LCT, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 2005;352:238-244 (Pubitemid 40110812)
16. King SP, Smith SC, Hirshfeld JW, et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American college of cardiology/ American heart association task force on practice guidelines. J Am Coll Cardiol 2008;51:172-209.
17. Eagle KA, Guyton RA, Davidoff R, et al. American College of Cardiology. American Heart Association. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004;110:340-437. (Pubitemid 39328205)
18. Ferrari E, Benhaou M, Cerboni P, Marcel B. Coronary syndromes following aspirin withdrawal. A special risk for late stent thrombosis. J Am Coll Cardiol 2005;45;456-459 (Pubitemid 40186800)
19. Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009;301:937-944